科研领域：
1.重组蛋白类和病毒类基因工程药物的制备及机理研究。
2.基于肿瘤和糖尿病分子靶点构建抑制剂筛选平台，对生物来源的天然产物进行药物筛选；使用分子生物学、细胞生物学、生物化学和药理学的方法研究药物的作用的机理，并探索肿瘤和糖尿病新的药物作用靶点。

代表性论文：
1. Xuehui Gao; Jie Kang; Xiangke Li; Chuan Chen*; Duqiang Luo*; Deletion of the tyrosine phosphatase Shp2 in cervical cancer cells promotes reprogramming of glutamine metabolism. FASEB J, 2023, 37, e22880
2. Huibin Xu; Xiaoman Shen; Xiangke Li; Xiaohui Yang; Chuan Chen*; Duqiang Luo*; The natural product dehydrocurvularin induces apoptosis of gastric cancer cells by activating PARP-1 andcaspase-3, Apoptosis, 2023, 28(3-4):525-538
3. Fan Liang; Xiangke Li; Xiaoman Shen; Runlei Yang; Chuan Chen*; Expression profiles and functional prediction of histone acetyltransferases of the MYST family in kidney renal clear cell carcinoma, BMC Cancer, 2023, 23(1):586.
4. Jie Kang; Chunqing Li; Xuehui Gao; Zhiqin Liu; Chuan Chen*; Duqiang Luo*; Metformininhibits tumor growth and affects intestinal flora in diabetic tumor-bearing mice, European Journal of Pharmacology, 2021, 912(5): 174605-174605
5. Chuan Chen; Ziyue Zhao; Qian Dong; Xuehui Gao; Huibin Xu; Runlei Yang; Jianchun Qin*; Duqiang Luo*; Anti-Tumor Activity and Underlying Mechanism of Phomoxanthone B in MCF7 Cells, Anti-cancer Agents in Medicinal Chemistry, 2021, 21(14): 1825-1834
6. Runlei Yang; Qian Dong; Huibin Xu; Xuehui Gao; Ziyue Zhao; Jianchun Qin; Chuan Chen*; Duqiang Luo*; Identification of phomoxanthone A and B as protein tyrosine phosphatase inhibitors. ACS Omega, 2020, 5(40): 25927-25935
7. 康洁;李春青;高雪惠;许慧彬; 陈川*;罗都强*; 2 型糖尿病肿瘤小鼠模型的建立及其肠道菌群分析,中国科学, 2021, 51(9): 1308-1318